Itracon 200 mg Tablet is an antifungal medication manufactured by Navana Pharmaceuticals Ltd., containing 200 mg of Itraconazole as the active ingredient. Itraconazole is a triazole antifungal agent that works by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes. This disruption leads to increased membrane permeability and ultimately the death of the fungal cell.
Indications: Itracon 200 mg Tablet is indicated for the treatment of various fungal infections, including:
Onychomycosis (fungal nail infections)
Tinea corporis (ringworm of the body)
Tinea cruris (jock itch)
Tinea pedis (athlete's foot)
Tinea manuum (fungal infection of the hands)
Vulvovaginal candidiasis (yeast infection of the vagina)
Fungal keratitis (infection of the cornea)
Pityriasis versicolor (skin infection causing discolored patches)
Oropharyngeal candidiasis (thrush)
Systemic fungal infections such as aspergillosis, candidiasis, and cryptococcosis when other treatments are ineffective
Antifungal prophylaxis to prevent systemic fungal infections in severely neutropenic patients